ConductScience.org, home

Paper430189

Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent.

Wieland DM and 3 others. J Nucl Med, 1979. Cited by 100 papers, by iCite.

Cite this record

ConductScience Library. Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent. Papers, record 430189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/430189

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent.
PubMed
Journal
J Nucl Med
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
100
iCite
Relative citation ratio, by iCite
3.92
iCite
Revised in PubMed
2022-04-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wieland DMD M
2Swanson DPD P
3Brown LEL E
4Beierwaltes WHW H

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenal MedullaMajor topic
Bretylium CompoundsMajor topic
Iodine RadioisotopesMajor topic
Animals
Dogs
Female
Iodobenzenes
Radionuclide Imaging
Structure-Activity Relationship
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.

PMIDTitleJournalYearIn PapersSource
39804528Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.Mol Neurobiol2025https://conductscience.org/library/papers/39804528PubMed
39770405Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39770405PubMed
38656630Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis.Ann Nucl Med2024https://conductscience.org/library/papers/38656630PubMed
37445504Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells.J Clin Med2023https://conductscience.org/library/papers/37445504PubMed
37376181Clinical Advances and Perspectives in Targeted Radionuclide Therapy.Pharmaceutics2023https://conductscience.org/library/papers/37376181PubMed
37145019Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.Cancer Med2023https://conductscience.org/library/papers/37145019PubMed
32549040MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders.Front Med (Lausanne)2020https://conductscience.org/library/papers/32549040PubMed
31380451Prediction of ong-term ardiac vents by 123I-meta-odobenzylguanidine maging after acute yocardial nfarction and eperfusion herapy.Asia Ocean J Nucl Med Biol2019https://conductscience.org/library/papers/31380451PubMed
31330766Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine.Cancers (Basel)2019https://conductscience.org/library/papers/31330766PubMed
31110198A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.Sci Rep2019https://conductscience.org/library/papers/31110198PubMed
28974600Molecular radiotheranostics for neuroendocrine tumours.Clin Med (Lond)2017https://conductscience.org/library/papers/28974600PubMed
28864611Norepinephrine Transporter as a Target for Imaging and Therapy.J Nucl Med2017https://conductscience.org/library/papers/28864611PubMed
25975946Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.J Nucl Cardiol2015https://conductscience.org/library/papers/25975946PubMed
24523752A convenient Simple Method for Synthesis of Meta-iodobenzylguanidine (MIBG).Iran J Pharm Res2013https://conductscience.org/library/papers/24523752PubMed
23674235Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.Curr Oncol Rep2013https://conductscience.org/library/papers/23674235PubMed
22628250Molecular imaging of adrenal neoplasms.J Surg Oncol2012https://conductscience.org/library/papers/22628250PubMed
22231492Aberrant I-123 MIBG uptake in a gastrointestinal stromal tumour.Updates Surg2013https://conductscience.org/library/papers/22231492PubMed
21167384Molecular imaging of neuroendocrine tumors.Semin Oncol2010https://conductscience.org/library/papers/21167384PubMed
20307711Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.Pediatr Clin North Am2010https://conductscience.org/library/papers/20307711PubMed
20016892Efficacy of using a standard activity of (131)I-MIBG therapy in patients with disseminated neuroendocrine tumours.Eur J Nucl Med Mol Imaging2010https://conductscience.org/library/papers/20016892PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/430189

GET https://conductscience.org/api/papers/v1/430189/cited_by?page=2